Immunitas Therapeutics
Ming “Tommy” Tang is the Director of Computational Biology at Immunitas. Prior to joining Immunitas Tommy was at Dana-Farber Cancer Institute and Harvard University where he led a team to analyze immune-oncology-related single-cell sequencing datasets and spearheaded an NIH-funded project called Cancer Immunological Data Commons. Tommy has a wealth of experience as a computational biologist with over eight years in analyzing large-scale (epi)genomic/transcriptomic data and automating the analysis by using workflow languages such as Snakemake. He is an integral part of the team as we build out the computational biology expertise at Immunitas. Prior to joining Dana-Farber, Tommy received his Ph.D. in Genetics and Genomics from the University of Florida and completed a three-year postdoc at MD Anderson. He has a keen interest in teaching computational skills to wet biologists and is a certified instructor for Data Carpentry.
This person is not in any offices
Immunitas Therapeutics
Immunitas is an immuno-oncology therapeutics company advancing multiple programs to the clinic. Immunitas’ programs are derived from a cross-functional, highly integrated, single-cell genomics platform that enables rapid target identification and validation in parallel with antibody discovery and engineering.